CPIX
NASDAQ · Pharmaceuticals
Cumberland Pharmaceuticals
$7.37
+0.05 (+0.68%)
Open$7.43
Previous Close$7.32
Day High$7.45
Day Low$7.09
52W High$9.28
52W Low$1.85
Volume—
Avg Volume35.1K
Market Cap105.63M
P/E Ratio—
EPS$-0.49
SectorPharmaceuticals
Analyst Ratings
Strong Sell
6 analysts
Price Target
+381.0% upside
Current
$7.37
$7.37
Target
$35.45
$35.45
$27.92
$35.45 avg
$53.56
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 43.97M | 43.13M | 7.91M |
| Net Income | -2,800,686 | -2,472,405 | 1.22M |
| Profit Margin | -6.4% | -6.1% | 15.4% |
| EBITDA | 1.34M | 1.25M | 2.16M |
| Free Cash Flow | — | — | 556.1K |
| Rev Growth | +2.0% | +2.0% | +3.2% |
| Debt/Equity | 0.21 | 0.21 | 0.66 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,170.14 | +0.45% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.19 | -0.10% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $150.91 | +0.94% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.93 | +0.68% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.25 | -0.59% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $72.86 | +2.15% | 11.5 | 30.15B |